MEDIUM
CVE-2026-41281
CWE-319Published: May 14, 2026· Updated: May 14, 2026
6.3
CVSS v3.1
EPSS:0.01%probability of exploitation in 30 daysPercentile:3.1th
Official Description
Android App "あんしんフィルター for au" provided by KDDI CORPORATION contains Cleartext Transmission of Sensitive Information (CWE-319) vulnerability. A man-in-the-middle attacker may access and modify communications transmitted in plaintext, potentially resulting in information disclosure or data tampering.
Technical Analysis
CVE-2026-41281 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeX
Impact
Confidentiality
Integrity
Availability
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
All References (1)
Quick Facts
CVE IDCVE-2026-41281
CVSS Score6.3 / 10
SeverityMEDIUM
WeaknessCWE-319
CISA KEVNo
EPSS (30d)0.01%
PublishedMay 14, 2026
Related CVEs (CWE-319)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2026-41281 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.